Use of multikinase inhibitors/lenvatinib in singular thyroid cancer scenarios

Overview publication

TitleUse of multikinase inhibitors/lenvatinib in singular thyroid cancer scenarios
DateOctober 1st, 2022
Issue nameCancer Medicine
Issue numberv11.S1 p3-4
DOI10.1002/cam4.5154
AuthorsZafón C & Castelo B
MTGsMTG8
Read Read publication